Interchageable Use of Proton Pump Inhibitors Based on Relative Potency—Systematic Review and Meta-Analysis

Although proton pump inhibitors (PPIs) are widely used, their relative; potency and ideal dosing regimens are unclear. We used omeprazole equivalency; and the surrogate biomarker, pH4time, to compare PPI effectiveness when given once, twice, or 3 times daily.

http://ift.tt/2ftzRrJ